Company

HLB PHARMA

History

CompanyHistory
  • 2005~2023

    Launch period

    2023.05Established Korean Arthritis R&D Center
    2023.04Launched healthcare brand ‘Quanchell’
    2023.02Reloacted the R&D Center to Gunpo
    2022.12Achieved record sales 100 Billion Won
    2021.04Relocated the Laboratory to Dongtan
    2021.02Acquired the Hyangnam Plant
    2020.10 Changed the company name to'HLB Pharmaceutical Co., Ltd.'
    2020.03Relocated the head office to Munjeong-dong, Seoul
    2020.02Renamed to MEDIFORUM PHARMACEUTICAL Co., Ltd.
    2019.11Acquired C-TRI
    2015.12Listed on KOSDAQ
    2015.02Established Chuncheon Laboratory
    2013.11Obtained BGMP certification of peptide synthesis plant in Namyangju
    2011.07Completed the peptide synthesis plant in Namyangju
    2009.02Relocated the head office and Central Laboratory to Namyangju
  • 2000~2004

    Growth period

    2004.12Awarded a prize from the Prime Minister at the Korea Tech Show
    2003.12Awarded the Grand Prize of Industrial Cooperation from the Minister of Trade, Industry and Energy
    2002.09Merged with Chirogene Co., Ltd.
    2001.12Awarded a commendation from the Governor of Gyeonggi-do
    2001.11Awarded a commendation from the Minister of Trade, Industry and Energy at the 5th National Venture Business Competition
    2000.07Established Namyangju Laboratory
  • 1998~1999

    Foundation period

    1999.11Acquired the Namyangju factory of Bayer Korea
    1999.01Registered as a venture business
    1998.08Established the Central Laboratory
    1998.04Established C-TRI Co., Ltd.